BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 11522385)

  • 21. Recognition of a glycosylation substrate by the O-GlcNAc transferase TPR repeats.
    Rafie K; Raimi O; Ferenbach AT; Borodkin VS; Kapuria V; van Aalten DMF
    Open Biol; 2017 Jun; 7(6):. PubMed ID: 28659383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional significance of O-GlcNAc modification in regulating neuronal properties.
    Hwang H; Rhim H
    Pharmacol Res; 2018 Mar; 129():295-307. PubMed ID: 29223644
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Eustice M; Bond MR; Hanover JA
    Biochem Soc Trans; 2017 Apr; 45(2):427-436. PubMed ID: 28408483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular and extracellular O-linked N-acetylglucosamine in the nervous system.
    Ogawa M; Sawaguchi S; Kamemura K; Okajima T
    Exp Neurol; 2015 Dec; 274(Pt B):166-74. PubMed ID: 26278182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tools for probing and perturbing O-GlcNAc in cells and in vivo.
    Cecioni S; Vocadlo DJ
    Curr Opin Chem Biol; 2013 Oct; 17(5):719-28. PubMed ID: 23906602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
    Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
    J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
    Isono T
    PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell development and the physiological role of O-GlcNAc.
    Abramowitz LK; Hanover JA
    FEBS Lett; 2018 Dec; 592(23):3943-3949. PubMed ID: 29904918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. O-GlcNAc modification affects the ATM-mediated DNA damage response.
    Miura Y; Sakurai Y; Endo T
    Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
    Johnson B; Opimba M; Bernier J
    Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of a missense mutation in the
    Vaidyanathan K; Niranjan T; Selvan N; Teo CF; May M; Patel S; Weatherly B; Skinner C; Opitz J; Carey J; Viskochil D; Gecz J; Shaw M; Peng Y; Alexov E; Wang T; Schwartz C; Wells L
    J Biol Chem; 2017 May; 292(21):8948-8963. PubMed ID: 28302723
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic recoding to dissect the roles of site-specific protein O-GlcNAcylation.
    Gorelik A; Bartual SG; Borodkin VS; Varghese J; Ferenbach AT; van Aalten DMF
    Nat Struct Mol Biol; 2019 Nov; 26(11):1071-1077. PubMed ID: 31695185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical observations that shaped our understanding of the function(s) of intracellular glycosylation (O-GlcNAc).
    Zachara NE
    FEBS Lett; 2018 Dec; 592(23):3950-3975. PubMed ID: 30414174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. O-GlcNAc transferase inhibitors: current tools and future challenges.
    Trapannone R; Rafie K; van Aalten DM
    Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
    Nagel AK; Ball LE
    Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting O-glycosyltransferase (OGT) to promote healing of diabetic skin wounds.
    Runager K; Bektas M; Berkowitz P; Rubenstein DS
    J Biol Chem; 2014 Feb; 289(9):5462-6. PubMed ID: 24398691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation.
    Tallent MK; Varghis N; Skorobogatko Y; Hernandez-Cuebas L; Whelan K; Vocadlo DJ; Vosseller K
    J Biol Chem; 2009 Jan; 284(1):174-181. PubMed ID: 19004831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
    Haltiwanger RS; Grove K; Philipsberg GA
    J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins.
    Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM
    Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.